Medicenna Therapeutics Corp (TSX:MDNA)
C$ 2.4 0.03 (1.27%) Market Cap: 183.44 Mil Enterprise Value: 147.81 Mil PE Ratio: 0 PB Ratio: 8.02 GF Score: 42/100

Medicenna Therapeutics Corp. - Special Call Transcript

Dec 11, 2020 / 04:00PM GMT
Release Date Price: C$5.07 (+2.01%)
Operator

Good afternoon, and welcome to the Medicenna KOL webinar on MDNA55 for the treatment of recurrent glioblastoma multiforme. (Operator Instructions) As a reminder, this webinar is being recorded, and a replay will be made available on the Medicenna website following the event. .

I would now like to turn the call over to your host, Dr. Fahar Merchant, President and Chief Executive Officer of Medicenna. Please go ahead, Doctor.

Fahar Merchant
Medicenna Therapeutics Corp. - Founder, Chairman, CEO & President

Thank you, operator. Good morning, everyone, and welcome to today's key opinion leader event. Before I begin, I would like to remind everyone that during the presentations and the Q&A session to follow, forward-looking statements may be made as disclosed on this slide.

Next slide, please. I would also like to thank our key opinion leaders, Dr. David Reardon, Dr. John Sampson; Dr. Ruthie Davi, and Dr. Amy McKee, for graciously taking the time to join us on the webcast today.

Next slide, please. So today's event will focus on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot